United States · Medical devices startup

Nanova Biomaterials Inc.

Nanova Biomaterials Inc.

Funding reportedLast round: Seed

Medical devicesColumbia, United States

About Nanova Biomaterials Inc.

Nanova Biomaterials Inc.

(NBI) is a medical device startup founded in 2007 by researchers from the University of Missouri. The company focuses on nanotechnology to create innovative orthopedic, surgical, and dental implants. Operating from a modern facility in Columbia, Missouri, NBI is committed to enhancing its products through rigorous research and development. NBI's product offerings include advanced dental solutions like flowable and universal composites, a carpule dispenser gun, teeth whitening gel, and sodium fluoride varnish. In the orthopedic sector, they manufacture specialized implants and anchors, including interference screws and FiberFixTM screw-in anchors. Additionally, their surgical devices, such as the Vas-Q-ClipSafe, provide secure closure mechanisms for surgical procedures. Nanova serves dental professionals, orthopedic surgeons, and surgical teams, emphasizing a user-centric design philosophy while maintaining a global reach.

What company datasets say Nanova Biomaterials Inc. raised

Funding, as reported

The last round reportedSeedJan 2014
Last round dateJan 2014

The company, in detail

What they build

Known for

medical equipment manufacturingorthopedic implantshospital & health caremedical devicessurgical devicesb2bdental consumables

Built with from their website

Reviews.ioMicrosoft TranslatorWordPress.orgFont AwesomeElementorYouTubeCloudFlareViewport MetaCloudflare WAFPageFly

+8 more

Facebook SDKX (Twitter)Shop PayCloudFlare CDNPriority HintsGoogle Font APIMicrosoft ExchangeApple Pay

Sector
Medical devices
Industry code
NAICS 33911, SIC 3841
Region
Missouri
Revenue
$36M a year, as listed
Full record
Every detail in the company directory

Medical devices in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Nanova Biomaterials Inc. in front of investors. Or tell us what we have wrong.